ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): a randomized, controlled trial...

Translational Block in Stroke: A Constructive and “Out-of-the-Box” Reappraisal

(2021) Athanasios Lourbopoulos et al.   Frontiers in Neuroscience

Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis

(2020) Simona Schiavi et al.   BRAIN

Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis

(2019) Sanam Dolati et al.   JOURNAL OF NEUROIMMUNOLOGY

Local Delivery of BDNF Enables Behavioural Recovery and Tissue Repair in Stroke-Injured Rats

(2019) Jaclyn M. Obermeyer et al.   TISSUE ENGINEERING PART A

Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: A systematic review and dose–response meta-analysis of randomized controlled trials

(2019) Payam Sarraf et al.   NUTRITION RESEARCH

Immunological Aspects of Approved MS Therapeutics

(2019) Paulus S. Rommer et al.   Frontiers in Immunology

Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial

(2018) Gary W. Small et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Supplementation with Curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer’s disease: A systematic review

(2018) Ianara Mendonca da Costa et al.   Current Neuropharmacology

MRI in multiple sclerosis

(2018) Matilde Inglese et al.   CURRENT OPINION IN NEUROLOGY

Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis

(2018) Emily Evans et al.   JAMA Neurology

Current advancements in promoting remyelination in multiple sclerosis

(2018) David Kremer et al.   Multiple Sclerosis Journal

Therapeutic potential of curcumin for multiple sclerosis

(2017) Munibah Qureshi et al.   NEUROLOGICAL SCIENCES

Colloidal Submicron-Particle Curcumin Exhibits High Absorption Efficiency—A Double-Blind, 3-Way Crossover Study—

(2015) Yoichi SUNAGAWA et al.   JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY

Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia

(2015) Matilde Inglese et al.   SCHIZOPHRENIA RESEARCH

Curcumin protects axons from degeneration in the setting of local neuroinflammation

(2014) Million Adane Tegenge et al.   EXPERIMENTAL NEUROLOGY

Study of curcumin immunomodulatory effects on reactive astrocyte cell function

(2014) Mir Hadi Seyedzadeh et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Neuroimaging of Multiple Sclerosis, Acute Disseminated Encephalomyelitis, and Other Demyelinating Diseases

(2013) Maxim Bester et al.   SEMINARS IN ROENTGENOLOGY

Curcumin Inhibits LPS-Induced CCL2 Expression via JNK Pathway in C6 Rat Astrocytoma Cells

(2012) Zhi-Jun Zhang et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Black holes in multiple sclerosis: definition, evolution, and clinical correlations

(2009) M. A. Sahraian et al.   ACTA NEUROLOGICA SCANDINAVICA

A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (BiocurcumaxTM), a novel bioenhanced preparation of curcumin

(2009) B Antony et al.   INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES

Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production

(2009) Lin Xie et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

BDNF Modulation of NMDA Receptors Is Activity Dependent

(2008) Robert A. Crozier et al.   JOURNAL OF NEUROPHYSIOLOGY

MMPs in the central nervous system: Where the good guys go bad

(2007) S AGRAWAL et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY